SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBio-Sustainable Future Enterprises Regulatory News (BSFA)

Share Price Information for Bio-Sustainable Future Enterprises (BSFA)

Share Price is delayed by 15 minutes
Get Live Data
1.125    -0.875 (-43.75%)
Bid:
1.00
Ask:
1.25
Spread: 0.25 (25.00%)
Market Cap: £1.88m
BSFA Live PriceLast checked at - London Stock Exchange

Intraday Bio-Sustainable Future Enterprises Share Chart

First Tannable A4-Sized Skin Achieved

10 Mar 2026 10:47

RNS Number : 0672W
BSF Enterprise PLC
10 March 2026
 

10 March 2026

BSF Enterprise PLC

First Tannable A4-Sized Skin Achieved

Scalable Process Unlocked for Elemental™; T-Rex Leather™ Showcase Confirmed for 2 April 2026

BSF Enterprise PLC (LSE:BSFA), the tissue-engineering innovator, is pleased to report a significant commercial milestone for its wholly-owned subsidiary Lab-Grown Leather Limited ("LGL"): the successful production of a fully tanned, scaffold-free skin reaching A4 sheet size and approaching 2mm thickness - achieved in a matter of weeks using LGL's proprietary Advanced Tissue Engineering Platform ("ATEP™").

 

Key Milestones Achieved

• A4-size tannable skin produced at industrially relevant thickness (~2mm)

• Scalable process developed over the last six months using ATEP™

• Scaffold-free architecture delivering bio-equivalent durability, breathability and patina

• Zero-waste geometry: skin cultivated to specification, eliminating traditional hide scrap rates

• T-Rex Leather™ website and social channels live; showcase event confirmed for 2 April 2026

 

Elemental™: A New Standard for High-Performance Luxury Materials

The Elemental™ product series represents the commercial embodiment of LGL's ATEP™. Over the past six months, the LGL team has engineered a repeatable, scalable process that takes animal cells and cultivates them into a tannable skin product at dimensions that are meaningful to luxury goods manufacturers. This first full tanning of the material - a critical processing step required before leather can be used in finished goods - confirms that Elemental™ is advancing through the technical readiness pathway towards commercial supply.

 

Unlike many competing bio-based or synthetic alternative materials, LGL's scaffold-free approach means the cells self-organise to produce a material that is bio-equivalent to conventional hide: retaining the structural integrity, tactile properties, and characteristic patina that luxury brands demand. The process can be tuned to produce leathers that are thinner, stronger, or with unique surface characteristics that would be impossible or unethical to source conventionally. Thus LGL is able to uniquely position ElementalTM as a high-end, low-intervention material, setting the standard for a new generation of leather and cultivating a new era for luxury.

 

T-Rex Leather™ - Where Technology Meets Rarity

One of the most distinctive and commercially compelling applications of LGL's platform is its ability to engineer material inspired by the cellular biology of rare and extinct species. T-Rex Leather™ leverages this capability to offer the luxury and fashion industries access to materials that are, by definition, unavailable by any other means - creating a genuine scarcity narrative that is entirely authentic and ethically sound.

 

This positions LGL in a unique category: not simply a "more sustainable" version of existing leather, but a genuinely new class of luxury material with intrinsic rarity, provenance, and a powerful story. The T-Rex Leather™ brand has now launched its website and social media presence, and a showcase event has been confirmed for 2 April 2026, which the Company expects to generate significant press and industry engagement.

See links:

https://www.instagram.com/t_rex_leather/

https://lab-grown-leather.com/t-rex-leather/

 

Elemental™ skin sample - A4 size, approaching 2mm thickness

Commercial Outlook

The achievement of a tannable skin at A4 scale and industrially relevant thickness is a key gate in LGL's commercialisation roadmap. The Company is now in a position to extend its engagement with luxury goods manufacturers, material distributors, and brand partners on the basis of a tangible, scalable and demonstrable product. LGL's IP-protected ATEP™ platform provides a defensible competitive moat across both the conventional luxury leather market and the emerging exotic/extinct species segment.

 

The Company will continue to update shareholders on progress, including the outcome of the 2 April 2026 T-Rex Leather™ showcase event.

 

END

 

Engage with the BSF Enterprise management team directly by asking questions, watching videosummaries and seeing what other shareholders have to say. Navigate to our Interactive Investorwebsite here:

 

https://bsfenterprise.com/link/ya3aRr

 

For further enquiries, please visit www.bsfenterprise.com or contact:

 

BSF Enterprise PLC

Geoff Baker - Chairman

Che Connon - CEO & Director

 

We encourage all investors to share questions on this announcement via our investor website.

https://bsfenterprise.com/s/a1f22b

Shard Capital (Broker)

Damon Heath

Isabella Pierre

 

0207 186 9000

0207 186 9927

AlbR Capital Limited (Broker)

Colin Rowbury

Jon Belliss

+44 (0)20 7469 0930

ISIN of the Ordinary Shares

is GB00BHNBDQ51.

SEDOL Code is BHNBDQ5.

 

 

 

Subscribe to our news alert service: https://bsfenterprise.com/s/bb9f43

 

About BSF Enterprise PLC

BSF Enterprise PLC (LSE:BSFA) develops and commercialises cutting-edge tissue-engineered solutions, including lab-grown leather (via LGL), cultivated meat, and corneal repair technologies. By leveraging its proprietary scaffold-free ATEP™ platform, BSF delivers sustainable, high-performance alternatives to conventional materials, targeting global markets where provenance, ethics, and performance are increasingly prized by consumers and brands alike.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBGGDXBSBDGLG
Date   Source Headline
12th Jun 20267:00 amRNSParis Auction Result
11th Jun 20267:00 amRNS£1 Million Convertible Loan Note
8th Jun 202611:59 amRNSShareholder meeting results
3rd Jun 20267:00 amRNSConditional Further Investment
2nd Jun 20268:50 amRNSTechnical White Paper on T-Rex Leather™
28th May 20267:00 amRNSAuction Update - May 2026
26th May 20267:00 amRNSStrategic Update May 2026
22nd May 20263:13 pmRNSPosting of Circular and Notice of General Meeting
5th May 20267:00 amRNST-Rex Leather™ handbag to be auctioned
17th Apr 202610:00 amRNSAdmission of Shares
13th Apr 20267:00 amRNSStrategic Shareholding Update
7th Apr 20267:00 amRNSWorld’s First T-Rex Leather Handbag Unveiled
2nd Apr 20267:00 amRNSWorld First T-Rex Leather™ Product
19th Mar 20267:00 amRNSSupply Agreement with SeaWith
17th Mar 20267:00 amRNSLGL Tanning Milestones
17th Mar 20267:00 amRNSLGL Tanning Milestones
13th Mar 20267:00 amRNSFurther Update on Fundraise & Reorganisation
13th Mar 20267:00 amRNSFurther Update on Fundraise & Reorganisation
10th Mar 202610:47 amRNSFirst Tannable A4-Sized Skin Achieved
10th Mar 202610:47 amRNSFirst Tannable A4-Sized Skin Achieved
3rd Mar 202611:00 amRNSResult of Annual General Meeting
27th Feb 20267:00 amRNSUpdate on Proposed Equity Fundraise
9th Feb 20267:00 amRNSNotice of 2026 AGM
3rd Feb 20265:14 pmRNSAnnual Financial Report - Correction
2nd Feb 20267:00 amRNSAnnual Financial Report
19th Jan 20267:00 amRNSKERATO LIMITED SIGNS WITH QUEBEC PSO GRANT
17th Dec 202511:08 amRNSResult of General Meeting
16th Dec 20257:00 amRNS3D Bio-Tissues Signs Supply Agreement with SeaWith
15th Dec 20257:00 amRNSChanges to timetable for proposed Equity Fundraise
5th Dec 20259:50 amRNS-RBSF Enterprise launches new Investor website
1st Dec 20257:02 amRNSProposed Equity Fundraise - Strategic Direction
1st Dec 20257:00 amRNSEquity Fundraise & Notice of General Meeting
29th Aug 202510:47 amRNSResignation of Chairman
10th Jul 20257:00 amRNSAgreement
25th Jun 20257:00 amRNSInterim 2025 Results
23rd May 20257:00 amRNS15p Warrants Amended
21st May 20257:00 amRNSLab-Grown Leather Ltd Progress
28th Apr 202510:01 amRNSStrategic Investment
25th Apr 20259:48 amRNSJoint Venture
13th Mar 20257:00 amRNS3DBT Lab Grown Leather Commercialization
6th Mar 20253:51 pmRNSPublication of a Prospectus
5th Mar 202512:10 pmRNSResult of Annual General Meeting
11th Feb 20258:21 amRNSExpected admission of shares - Replacement
11th Feb 20257:00 amRNSAIM Admission - Update
10th Feb 20257:00 amRNSAGM Statement
31st Jan 202512:41 pmRNSAnnual Financial Report
31st Jan 202512:31 pmRNSAnnual Financial Report
21st Jan 20257:00 amRNSBSF Enterprise and Sartorius
27th Dec 20247:00 amRNSAdmission of Placing Shares
18th Dec 20247:00 amRNS3DBT Ltd Secures Prestigious Northern Accelerator

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.